keyword
https://read.qxmd.com/read/38622915/multifaceted-physiological-and-therapeutical-impact-of-curcumin-on-hormone-related-endocrine-dysfunctions-a-comprehensive-review
#21
REVIEW
Xiuying Wang, Wei Zhang, Shengxue Zhou
Over the past five decades, Curcumin (Cur), derived from turmeric (Curcuma longa), has gained considerable attention for its potential therapeutic applications. Synthesizing insights from clinical trials conducted over the last 25 years, this review delves into diseases where Cur has demonstrated promise, offering a nuanced understanding of its pharmacokinetics, safety, and effectiveness. Focusing on specific examples, the impact of Cur on various human diseases is explored. Endocrine glands and associated signaling pathways are highlighted, elucidating how Cur influences cellular signaling...
April 15, 2024: Phytotherapy Research: PTR
https://read.qxmd.com/read/38622327/the-case-for-centralization-of-care-in-penile-cancer-respecting-geographical-needs
#22
JOURNAL ARTICLE
Giuseppe Basile, Andrea Necchi, Gagan Prakash, Karima Oualla, Philippe E Spiess, Peter A S Johnstone
No abstract text is available yet for this article.
April 15, 2024: Nature Reviews. Urology
https://read.qxmd.com/read/38622326/a-caf-subpopulation-promotes-lvi-in-early-stage-bladder-cancer
#23
JOURNAL ARTICLE
Maria Chiara Masone
No abstract text is available yet for this article.
April 15, 2024: Nature Reviews. Urology
https://read.qxmd.com/read/38622310/targeting-immunogenic-cell-stress-and-death-for-cancer-therapy
#24
REVIEW
Lorenzo Galluzzi, Emma Guilbaud, Darby Schmidt, Guido Kroemer, Francesco M Marincola
Immunogenic cell death (ICD), which results from insufficient cellular adaptation to specific stressors, occupies a central position in the development of novel anticancer treatments. Several therapeutic strategies to elicit ICD - either as standalone approaches or as means to convert immunologically cold tumours that are insensitive to immunotherapy into hot and immunotherapy-sensitive lesions - are being actively pursued. However, the development of ICD-inducing treatments is hindered by various obstacles...
April 15, 2024: Nature Reviews. Drug Discovery
https://read.qxmd.com/read/38621469/trastuzumab-deruxtecan-in-breast-cancer
#25
REVIEW
Miguel Martín, Atanasio Pandiella, Emilio Vargas-Castrillón, Elena Díaz-Rodríguez, Teresa Iglesias-Hernangómez, Concha Martínez Cano, Inés Fernández-Cuesta, Elena Winkow, Maria Francesca Perelló
Trastuzumab deruxtecan (T-DXd) is an antibody-drug conjugate (ADC) consisting of a humanised, anti-human epidermal growth factor receptor 2 (HER2) monoclonal antibody covalently linked to a topoisomerase I inhibitor cytotoxic payload (DXd). The high drug-to-antibody ratio (8:1) ensures a high DXd concentration is delivered to target tumour cells, following internalisation of T-DXd and subsequent cleavage of its tetrapeptide-based linker. DXd's membrane-permeable nature enables it to cross cell membranes and potentially exert antitumour activity on surrounding tumour cells regardless of HER2 expression...
April 13, 2024: Critical Reviews in Oncology/hematology
https://read.qxmd.com/read/38618889/an-update-on-the-development-on-tubulin-inhibitors-for-the-treatment-of-solid-tumors
#26
REVIEW
Prasanna Anjaneyulu Yakkalaa, Shaik Rahaman, P S Lakshmi Soukya, Sajeli Ahil Begum, A Kamal
INTRODUCTION: Microtubules play a vital role in cancer therapeutics. They are implicated in tumorigenesis, thus inhibiting tubulin polymerization in cancer cells, and have now become a significant target for anticancer drug development. A plethora of drug molecules has been crafted to influence microtubule dynamics and presently, numerous tubulin inhibitors are being investigated. This review discusses the recently developed inhibitors including natural products, and also examines the preclinical and clinical data of some potential molecules...
April 15, 2024: Expert Opinion on Therapeutic Targets
https://read.qxmd.com/read/38618731/role-of-natural-killer-cells-as-cell-based-immunotherapy-in-oral-tumor-eradication-and-differentiation-both-in-vivo-and-in-vitro
#27
JOURNAL ARTICLE
Kawaljit Kaur, Anahid Jewett
Despite advancements in the field of cancer therapeutics, the five-year survival rate remains low in oral cancer patients. Therefore, the effective therapeutics are needed against oral cancer. Also, several studies including ours, have shown severely suppressed function and number of NK cells in oral cancer patients. In this review, we discuss the approach to inhibit the tumor growth and metastasis by direct killing or NK cell-mediated tumor differentiation. This review also provides an overview on supercharging NK cells using osteoclasts and probiotic bacteria, and their efficacy as cancer immunotherapeutic in humanized-BLT mice...
2024: Critical Reviews in Immunology
https://read.qxmd.com/read/38618730/current-and-future-states-of-natural-killer-cell-based-immunotherapy-in-hepatocellular-carcinoma
#28
JOURNAL ARTICLE
Tu Nguyen, Po-Chun Chen, Janet Pham, Kawaljit Kaur, Steven S Raman, Anahid Jewett, Jason Chiang
Natural killer (NK) cells are innate lymphoid cells that exhibit high levels of cytotoxicity against NK-specific targets. NK cells also produce various cytokines, and interact with T cells, B cells, and dendritic cells to effectively serve as frontliners of the innate immune system. Produce various cytokines, and interact with T cells, B cells, and dendritic cells to effectively serve as frontliners of the innate immune system. Moreover, NK cells constitute the second most common immune cell in the liver. These properties have drawn significant attention towards leveraging NK cells in treating liver cancer, especially hepatocellular carcinoma (HCC), which accounts for 75% of all primary liver cancer and is the fourth leading cause of cancer-related death worldwide...
2024: Critical Reviews in Immunology
https://read.qxmd.com/read/38618206/an-artificial-intelligence-model-for-detecting-pathological-lymph-node-metastasis-in-prostate-cancer-using-whole-slide-images-a-retrospective-multicentre-diagnostic-study
#29
JOURNAL ARTICLE
Shaoxu Wu, Yun Wang, Guibin Hong, Yun Luo, Zhen Lin, Runnan Shen, Hong Zeng, Abai Xu, Peng Wu, Mingzhao Xiao, Xiaoyang Li, Peng Rao, Qishen Yang, Zhengyuan Feng, Quanhao He, Fan Jiang, Ye Xie, Chengxiao Liao, Xiaowei Huang, Rui Chen, Tianxin Lin
BACKGROUND: The pathological examination of lymph node metastasis (LNM) is crucial for treating prostate cancer (PCa). However, the limitations with naked-eye detection and pathologist workload contribute to a high missed-diagnosis rate for nodal micrometastasis. We aimed to develop an artificial intelligence (AI)-based, time-efficient, and high-precision PCa LNM detector (ProCaLNMD) and evaluate its clinical application value. METHODS: In this multicentre, retrospective, diagnostic study, consecutive patients with PCa who underwent radical prostatectomy and pelvic lymph node dissection at five centres between Sep 2, 2013 and Apr 28, 2023 were included, and histopathological slides of resected lymph nodes were collected and digitised as whole-slide images for model development and validation...
May 2024: EClinicalMedicine
https://read.qxmd.com/read/38617971/a-bibliometric-analysis-of-the-research-landscape-on-vascular-normalization-in-cancer
#30
JOURNAL ARTICLE
Hanghang Xie, Shan Wang, Dongling Niu, Chao Yang, Hongmei Bai, Ting Lei, Hongli Liu
Tumor vascular normalization profoundly affects the advancement of cancer therapy. Currently, with the rapid increase in research on tumor vascular normalization, few analytical and descriptive studies have investigated the trends in its development, key research power, present research hotspots, and future outlooks. In this study, articles and reviews published between January 1, 2003, and October 29, 2022 were retrieved from Web of Science database. Subsequently, published research trends, countries/regions, institutions, authors, journals, references, and keywords were analyzed based on traditional bibliometric laws (such as Price's exponential growth, Bradford's, Lotka's, and Zipf's)...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38617672/application-of-multifunctional-nanozymes-in-tumor-therapy
#31
REVIEW
Lihua Shao, Xueyuan Wang, Xiao Du, Shaoping Yin, Yun Qian, Yawen Yao, Lin Yang
Tumors are one of the main diseases threatening human life and health. The emergence of nanotechnology in recent years has introduced a novel therapeutic avenue for addressing tumors. Through the amalgamation of nanotechnology's inherent attributes with those of natural enzymes, nanozymes have demonstrated the ability to initiate catalytic reactions, modulate the biological microenvironment, and facilitate the adoption of multifaceted therapeutic approaches, thereby exhibiting considerable promise in the realm of cancer treatment...
April 9, 2024: ACS Omega
https://read.qxmd.com/read/38615876/treating-cancer-through-modulating-exosomal-protein-loading-and-function-the-prospects-of-natural-products-and-traditional-chinese-medicine
#32
REVIEW
Lulu Meng, Chao Zhang, Pei Yu
Exosomes, small yet vital extracellular vesicles, play an integral role in intercellular communication. They transport critical components, such as proteins, lipid bilayers, DNA, RNA, and glycans, to target cells. These vesicles are crucial in modulating the extracellular matrix and orchestrating signal transduction processes. In oncology, exosomes are pivotal in tumor growth, metastasis, drug resistance, and immune modulation within the tumor microenvironment. Exosomal proteins, noted for their stability and specificity, have garnered widespread attention...
April 12, 2024: Pharmacological Research: the Official Journal of the Italian Pharmacological Society
https://read.qxmd.com/read/38614820/eau-eanm-estro-esur-isup-siog-guidelines-on-prostate-cancer-2024-update-part-i-screening-diagnosis-and-local-treatment-with-curative-intent
#33
REVIEW
Philip Cornford, Roderick C N van den Bergh, Erik Briers, Thomas Van den Broeck, Oliver Brunckhorst, Julie Darraugh, Daniel Eberli, Gert De Meerleer, Maria De Santis, Andrea Farolfi, Giorgio Gandaglia, Silke Gillessen, Nikolaos Grivas, Ann M Henry, Michael Lardas, Geert J L H van Leenders, Matthew Liew, Estefania Linares Espinos, Jan Oldenburg, Inge M van Oort, Daniela E Oprea-Lager, Guillaume Ploussard, Matthew J Roberts, Olivier Rouvière, Ivo G Schoots, Natasha Schouten, Emma J Smith, Johan Stranne, Thomas Wiegel, Peter-Paul M Willemse, Derya Tilki
BACKGROUND AND OBJECTIVE: The European Association of Urology (EAU)-European Association of Nuclear Medicine (EANM)-European Society for Radiotherapy and Oncology (ESTRO)-European Society of Urogenital Radiology (ESUR)-International Society of Urological Pathology (ISUP)-International Society of Geriatric Oncology (SIOG) guidelines provide recommendations for the management of clinically localised prostate cancer (PCa). This paper aims to present a summary of the 2024 version of the EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on the screening, diagnosis, and treatment of clinically localised PCa...
April 12, 2024: European Urology
https://read.qxmd.com/read/38614043/natural-products-and-derivatives-for-breast-cancer-treatment-from-drug-discovery-to-molecular-mechanism
#34
REVIEW
Jing Zhang, Yongya Wu, Yanhong Li, Shutong Li, Jiaxi Liu, Xiao Yang, Guiyang Xia, Guan Wang
BACKGROUND: Breast cancer stands as the most common malignancy among women globally and a leading cause of cancer-related mortality. Conventional treatments, such as surgery, hormone therapy, radiotherapy, chemotherapy, and small-molecule targeted therapy, often fall short of addressing the complexity and heterogeneity of certain breast cancer subtypes, leading to drug resistance and metastatic progression. Thus, the search for novel therapeutic targets and agents is imperative. Given their low toxicity and abundant variety, natural products and their derivatives are increasingly considered valuable sources for small-molecule anticancer drugs...
April 7, 2024: Phytomedicine
https://read.qxmd.com/read/38613805/application-of-natural-language-processing-in-electronic-health-record-data-extraction-for-navigating-prostate-cancer-care-a-narrative-review
#35
JOURNAL ARTICLE
Ansh Bhatia, Renil Titus, Joao G Porto, Jonathan Katz, Diana Lopategui, Robert Marcovich, Dipen J Parekh, Hemendra Navinchandra Shah
INTRODUCTION: Natural Language Processing (NLP)-based data extraction from electronic health records (EHRs) holds significant potential to simplify clinical management and aid research. This review aims to evaluate the current landscape of NLP-based data extraction in prostate cancer (PCa) management. MATERIALS AND METHODS: We conducted a literature search of PubMed and Google Scholar databases using the keywords: "Natural Language Processing," "Prostate Cancer," "data extraction," and "EHR...
April 13, 2024: Journal of Endourology
https://read.qxmd.com/read/38613330/retrospective-review-of-the-toxicities-and-change-in-dosing-patterns-for-pegaspargase-in-patients-with-acute-lymphoblastic-leukemia-lymphoma-and-t-cell-lymphoma
#36
JOURNAL ARTICLE
Grace Baek, Miryoung Kim, Madison Lee, Shan O'Connor, Lauren Held, Lars van der Laan, Ryan D Cassaday
INTRODUCTION: Pegaspargase (PEG) is a key component of standard regimens for acute lymphoblastic leukemia/lymphoma (ALL) and extranodal natural killer/T-cell lymphoma (NKTCL). Emerging evidence suggests an opportunity to decrease incidence of PEG-associated toxicities with dose capping, but evidence is limited. This study aims to evaluate whether a significant difference in PEG-associated toxicities related to dosing strategy exists and to identify patient-specific or regimen-specific factors for PEG-related toxicity...
April 13, 2024: Journal of Oncology Pharmacy Practice
https://read.qxmd.com/read/38612911/informed-by-cancer-stem-cells-of-solid-tumors-advances-in-treatments-targeting-tumor-promoting-factors-and-pathways
#37
REVIEW
Maya R MacLean, Olivia L Walker, Raj Pranap Arun, Wasundara Fernando, Paola Marcato
Cancer stem cells (CSCs) represent a subpopulation within tumors that promote cancer progression, metastasis, and recurrence due to their self-renewal capacity and resistance to conventional therapies. CSC-specific markers and signaling pathways highly active in CSCs have emerged as a promising strategy for improving patient outcomes. This review provides a comprehensive overview of the therapeutic targets associated with CSCs of solid tumors across various cancer types, including key molecular markers aldehyde dehydrogenases, CD44, epithelial cellular adhesion molecule, and CD133 and signaling pathways such as Wnt/β-catenin, Notch, and Sonic Hedgehog...
April 7, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38612768/protein-arginine-methyltransferases-in-pancreatic-ductal-adenocarcinoma-new-molecular-targets-for-therapy
#38
REVIEW
Kritisha Bhandari, Wei-Qun Ding
Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignant disease with a low 5-year overall survival rate. It is the third-leading cause of cancer-related deaths in the United States. The lack of robust therapeutics, absence of effective biomarkers for early detection, and aggressive nature of the tumor contribute to the high mortality rate of PDAC. Notably, the outcomes of recent immunotherapy and targeted therapy against PDAC remain unsatisfactory, indicating the need for novel therapeutic strategies...
April 2, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38612718/cancer-stem-cells-from-definition-to-detection-and-targeted-drugs
#39
REVIEW
Barbara Ruszkowska-Ciastek, Katarzyna Kwiatkowska, Dorinda Marques-da-Silva, Ricardo Lagoa
Cancers remain the second leading cause of mortality in the world. Preclinical and clinical studies point an important role of cancer/leukaemia stem cells (CSCs/LSCs) in the colonisation at secondary organ sites upon metastatic spreading, although the precise mechanisms for specific actions are still not fully understood. Reviewing the present knowledge on the crucial role of CSCs/LSCs, their plasticity, and population heterogeneity in treatment failures in cancer patients is timely. Standard chemotherapy, which acts mainly on rapidly dividing cells, is unable to adequately affect CSCs with a low proliferation rate...
March 31, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38612567/decoding-the-versatile-landscape-of-autophagic-protein-vmp1-in-cancer-a-comprehensive-review-across-tissue-types-and-regulatory-mechanisms
#40
REVIEW
Felipe J Renna, Claudio D Gonzalez, Maria I Vaccaro
Autophagy, a catabolic process orchestrating the degradation of proteins and organelles within lysosomes, is pivotal for maintaining cellular homeostasis. However, its dual role in cancer involves preventing malignant transformation while fostering progression and therapy resistance. Vacuole Membrane Protein 1 (VMP1) is an essential autophagic protein whose expression, per se, triggers autophagy, being present in the whole autophagic flux. In pancreatic cancer, VMP1-whose expression is linked to the Kirsten Rat Sarcoma Virus (KRAS) oncogene-significantly contributes to disease promotion, progression, and chemotherapy resistance...
March 28, 2024: International Journal of Molecular Sciences
keyword
keyword
166206
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.